跳至主要内容
临床试验/EUCTR2012-000291-42-ES
EUCTR2012-000291-42-ES进行中(未招募)1 期

Effect of treatment with testosterone undecaonat in patients with Diabetes Mellitus Type 1 (DM-1) and hipogonadotrophic hypogonadism

Consorci Mar Parc de Salut de Barcelona (Parc de Salut Mar)0 个研究点开始时间: 2012年8月23日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • 1. Men older than or equal to 18.
  • 2. Submit a diagnosis of diabetes mellitus type 1 and hypogonadotropic hypogonadism, defined as:
  • ? Levels of total testosterone <8nmol / L(2.3 ng/mL), or total testosterone levels between 8 and 12 nmol / L (2.3-3.5 ng/mL)and calculated free testosterone <225 pmol / L (65 pg / mL).
  • ? Determination of LH below 8.6 mU / mL and / or FSH lower than 14.2 IU / L.
  • 3. Being able to provide informed consent before randomization and agree to abide by the study protocol.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 14
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 14

排除标准

  • 1. Existence of chronic debilitating disease such as kidney failure, cirrhosis, HIV, COPD, heart failure, ischemic heart disease.
  • 2. Patients with hypergonadotropic hypogonadism.
  • 3. Patients diagnosed with panhypopituitarism.
  • 4. Patients with hypogonadotropic hypogonadism secondary to pituitary tumor or empty sella.
  • 5. Patients with hypogonadotropic hypogonadism secondary to hyperprolactinemia.
  • 6. Patients with contraindications to the administration of testosterone: elevated PSA, breast carcinoma, prostate carcinoma, liver tumors
  • 7. Patients previously treated with testosterona
  • 8. Patients with allergy to testosterone and/or excipients.

研究者

相似试验

Effect of treatment with testosterone in diabetic... | 临床试验